ADC Therapeutics to Host Second Quarter 2024 Financial Results Conference Call on August 6, 2024
LAUSANNE, Switzerland, July 30, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in...
Year: 2024
Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs
Breakthrough Device Designations are granted by the U.S. FDA to expedite review of promising technologies that address high unmet needs...
Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2024
WESTLAKE VILLAGE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced...
InspireMD to Report Second Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, August 6th
-Conference call and webcast to be held at 8:30 a.m. EDT- TEL AVIV, Israel, and MIAMI, July 30, 2024 (GLOBE...
Day One Announces Oversubscribed $175.0 Million Private Placement
BRISBANE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a...
Foresight Diagnostics Expands Series B Financing to $73.75 Million to Advance the Foresight CLARITY™ MRD Platform
BOULDER, Colo., July 30, 2024 (GLOBE NEWSWIRE) -- Foresight Diagnostics, Inc. (“Foresight”), a leading diagnostics company specializing in the development...
Voyager Therapeutics Announces Second Quarter 2024 Conference Call and Webcast
LEXINGTON, Mass., July 30, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic...
Amicus Therapeutics to Announce Second Quarter 2024 Financial Results on August 8, 2024
PRINCETON, N.J., July 30, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a...
Arvinas Reports Second Quarter 2024 Financial Results and Provides Corporate Update
– Completed enrollment in the study lead-in for the VERITAC-3 Phase 3 trial in the first-line setting; continued enrollment globally...
BioXcel Therapeutics to Report Second Quarter 2024 Financial Results on August 6, 2024
NEW HAVEN, Conn., July 30, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence...
BioCardia Submits for FDA Approval of Morph® DNA™ Steerable Introducer Product Family
SUNNYVALE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. , a developer of cellular and cell-derived therapeutics for the treatment...
FendX Discusses Recent CDC Report on the Rise of Six Superbug Infections in the US
CDC reports burden of six hard-to-treat superbugs increased by a combined 20% in 2021 and 2022 compared with 2019CDC call...
AliveDx Announces Turnkey Solution for Precise, Automated Autoimmune Diagnostics
CHICAGO, July 30, 2024 /PRNewswire/ -- AliveDx, a global in vitro diagnostics company that aims to transform patient care, today...
DEEP Launches a Platform to Build Digital Measures of Health
HELSINKI, Finland, July 30, 2024 /PRNewswire/ -- DEEP Measures announces its collaborative platform to build digital measures in clinical trials,...
Alamar Biosciences Establishes European Headquarters and Distribution Center in Milan, Italy
FREMONT, Calif., July 30, 2024 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of...
Clarivate Introduces New OFF-X ™ Platform for Preclinical and Clinical Safety Intelligence
Empowering biopharma with enhanced safety insights to anticipate risks and unlock new competitive advantages LONDON, July 30, 2024 /PRNewswire/ --...
3Aware Welcomes Prashant Thumma as First Chief Technology Officer
INDIANAPOLIS, ID / ACCESSWIRE / July 30, 2024 / 3Aware, a leader in real-time surveillance and data solutions for medical...
German Medtech Protembis Gets €20 Million EIB Backing for Technology to Protect Brain During Heart Treatment
EIB offers Protembis venture debt for next-generation technology to reduce risk of brain injury in patients undergoing catheter-based heart treatment...
Kanazawa University research: High speed atomic force microscopy studies provide insights into influenza A viral replication
KANAZAWA, Japan, July 29, 2024 /PRNewswire/ -- Researchers at Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, IMDEA Nanoscience (Madrid, Spain)...
AngioDynamics to Participate in Upcoming Investor Conferences
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in...